Apollomics, Inc.

NASDAQ: APLM · Healthcare · Biotechnology

PublicHQ Foster City, CA · San MateoCIK 0001944885Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 32

v0.1 · 5/100 weight · pillars only

↑ market scale, Piotroski F · ↓ filing timeliness, balance-sheet leverage

Methodology →

Revenue TTM

$8.7M

Rev growth YoY (TTM)

+660.3%

Net income (FY)

-$53.9M

Employees

Market cap

$21.6M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$53.9M-$53.9M2024

Total assets$13.1M$13.1M2024

Liabilities$448.1M$448.1M2022

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Apollomics, Inc. earned -$53.9M in FY2024 net income.

Peers · Healthcare

Nova Leap Health Corp.75B+Guided Therapeutics, Inc.42D Retractable Technologies, Inc.57C Rockwell Medical, Inc.60C

Neighbors

San Mateo →

Meta Platforms, Inc.$201.0B87A Gilead Sciences, Inc.$29.4B87A Robinhood Markets, Inc.$4.5B67B Equinix, Inc.$9.2B73B Electronic Arts Inc.$7.5B82B+Revolution Medicines, Inc.$052D

Key facts

CEOHung-Wen Chen

SectorHealthcare

IndustryBiotechnology

HeadquartersFoster City, CA

ExchangeNASDAQ: APLM

Employees13

IPO date2021-11-26

Latest filings

6-K2026-06-24 6-K2026-04-27 20-F2026-04-24 6-K2026-04-01 6-K2025-12-22 6-K2025-12-12 6-K2025-11-19 6-K2025-11-18

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.